Neuroendocrine Risk for PTSD in Women
A legfontosabb adatok
- Ki végzi
- Emory University
- Hol
- Atlanta (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Fázis
- Korai 1. fázis
- Résztvevők
- 127 fő vett részt
- Kezdés
- 2019. nov. 11.
- Befejezés
- 2025. ápr. 30.
- A vizsgálat típusa
- Beavatkozással járó, 12 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Estradiol patch
- Placebo patch
- A regiszteradat frissítve
- 2026. július 22.
Ki vehet részt
- Életkor
- 18 év – 35 év
- Nem
- Csak nők
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 13 feltétel megnézéseKevesebb
Ki vehet részt
- African American women
- A menstrual period within the past 60 days
- Able and willing to give informed consent
- Must have a smart phone and willing to install the Clue app
Ki nem vehet részt
- Women currently taking any form of hormone-based birth control or other hormonal supplement
- Current psychoactive medication use
- Weight >250lbs (a maximum weight to allow for participants to fit comfortably inside the bore of the MRI machine) and typical physical contraindications for MRI such as metal implants
- Hypercoagulable conditions
- History of embolism
- Current symptoms of psychosis or bipolar disorder
- History of major head injury or neurological disorder
- Women who are pregnant or breastfeeding
- Nicotine use or smoking
Helyszínek itt: Egyesült Államok
- Grady Memorial HospitalAtlanta, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study will test for effects of estradiol (E2) on PTSD symptoms and functional magnetic resonance imaging (fMRI) indicators of stress vulnerability, in naturally-cycling women who are not using hormonal birth control. Enrollment will be targeted to create three groups within two cohorts (early follicular phase and luteal phase):
A teljes eredeti leírásKevesebb
1. PTSD: Women who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for PTSD 2. Trauma-Exposed (TC): Women matched for age and trauma exposure severity but without PTSD 3. Healthy Control (HC): Women matched for age, but without trauma history or psychiatric disorder (self-reported)
Women will be recruited through Grady Trauma Project (GTP), a large longstanding study of civilian trauma and PTSD conducted at Grady Memorial Hospital in Atlanta, Georgia.
A vizsgálat 12 csoportja
- Cohort 1: PTSD Receiving Estradiol then PlaceboA vizsgált kezelés
Participants with PTSD will record their first cycle with the Clue app. They will receive the estradiol patch during the second cycle, and the placebo patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 1: PTSD Receiving Placebo then EstradiolA vizsgált kezelés
Participants with PTSD will record their first cycle with the Clue app. They will receive the placebo patch during the second cycle, and the estradiol patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 1: Trauma without PTSD Receiving Estradiol then PlaceboMár használt kezelés, összehasonlításként
Participants with trauma exposure will record their first cycle with the Clue app. They will receive the estradiol patch during the second cycle, and the placebo patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 1: Trauma without PTSD Receiving Placebo then EstradiolMár használt kezelés, összehasonlításként
Participants with trauma exposure will record their first cycle with the Clue app. They will receive the placebo patch during the second cycle, and the estradiol patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 1: Healthy Controls Receiving Estradiol then PlaceboMár használt kezelés, összehasonlításként
Participants without trauma history or psychiatric disorder will record their first cycle with the Clue app. They will receive the estradiol patch during the second cycle, and the placebo patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 1: Healthy Controls Receiving Placebo then EstradiolMár használt kezelés, összehasonlításként
Participants without trauma history or psychiatric disorder will will record their first cycle with the Clue app. They will receive the placebo patch during the second cycle, and the estradiol patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 2: PTSD Receiving Estradiol then PlaceboA vizsgált kezelés
Participants with PTSD will begin daily urine ovulation tests on Day 11 of their first cycle, and will record the results with the Clue app. During the second month of cycle monitoring, the MRI will be scheduled 5-7 days after they record a positive ovulation test (during luteal phase) and they will use the estradiol patch before getting the MRI. They will apply the placebo patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 2: PTSD Receiving Placebo then EstradiolA vizsgált kezelés
Participants with PTSD will begin daily urine ovulation tests on Day 11 of their first cycle, and will record the results with the Clue app. During the second month of cycle monitoring, the MRI will be scheduled 5-7 days after they record a positive ovulation test (during luteal phase) and they will use the placebo patch before getting the MRI. They will apply the estradiol patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 2: Trauma Control Receiving Estradiol, then PlaceboMár használt kezelés, összehasonlításként
Participants with trauma exposure will begin daily urine ovulation tests on Day 11 of their first cycle, and will record the results with the Clue app. During the second month of cycle monitoring, the MRI will be scheduled 5-7 days after they record a positive ovulation test (during luteal phase) and they will use the estradiol patch before getting the MRI. They will apply the placebo patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 2: Trauma Control Receiving Placebo then EstradiolMár használt kezelés, összehasonlításként
Participants with trauma exposure will begin daily urine ovulation tests on Day 11 of their first cycle, and will record the results with the Clue app. During the second month of cycle monitoring, the MRI will be scheduled 5-7 days after they record a positive ovulation test (during luteal phase) and they will use the placebo patch before getting the MRI. They will apply the estradiol patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 2: Healthy Control Receiving Estradiol then PlaceboMár használt kezelés, összehasonlításként
Participants without trauma history or psychiatric disorder will begin daily urine ovulation tests on Day 11 of their first cycle, and will record the results with the Clue app. During the second month of cycle monitoring, the MRI will be scheduled 5-7 days after they record a positive ovulation test (during luteal phase) and they will use the estradiol patch before getting the MRI. They will apply the placebo patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
- Cohort 2: Healthy Control Receiving Placebo then EstradiolMár használt kezelés, összehasonlításként
Participants without trauma history or psychiatric disorder will begin daily urine ovulation tests on Day 11 of their first cycle, and will record the results with the Clue app. During the second month of cycle monitoring, the MRI will be scheduled 5-7 days after they record a positive ovulation test (during luteal phase) and they will use the placebo patch before getting the MRI. They will apply the estradiol patch during the third cycle.
Kezelés: Estradiol patch és Placebo patch
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The LOW E2 STUDY- Neuroendocrine Risk Mechanisms for Post-traumatic Stress Disorder in Women
- A regiszteradat frissítve
- 2026. július 22.